We Bring Top Biotech Executives Together to do the Deal


"There is no one in the biotechnology industry today who knows it better or the people in it than Bruce O'Brien."
Major Pharma CEO

Daedalus value for money

Experts in the Business of Biotechnology

Helping Life Sciences Companies
Thrive in a More Competitive Environment

No other firm in the industry brings its clients the same depth of knowledge as Daedalus Biotech Advisors. Combining a quarter century of operational experience with top scientists and clinicians in every field, supported by an unexcelled, proprietary database covering virtually every drug development and diagnostics program worldwide, and executives with more than one hundred years of combined personal biotech experience, Daedalus gives its clients the necessary edge in an increasingly challenging, globally competitive environment.



Drug Inlicensing

Credible drug candidates and the ability to generate them are the keys to biotech value. Daedalus' database includes virtually every compound in clinical and preclinical trials as well as drug development technologies worldwide. This combined with our experience gives Daedalus' clients a competitive advantage acquiring drug candidates.

Learn more >

Growth

Daedalus' executives have experience in scores of acquisitions, financings, joint ventures, and other transactions that merge the strengths of biotechs. We help firms achieve growth through improved pipelines as well as strengthened financial, executive, and clinical capability.

Learn more >

Cost Reduction

A lower cost business model with increased outsourcing is the direction in which the industry is evolving. With only a small percentage of compounds likely to succeed, it is imperative firms reduce costs and speed drug candidate development. Daedalus can make this happen by finding the right partner across the entire range of biotechnology services.

Learn more >